The vast majority of the early societal benefit and commercial success in biotechnology arose from expressing single genes in bacteria and mammalian cells, to manufacture pharmaceuticals. This approach, made possible by the universality of genetic information flow mechanisms among all organisms, has grown into a biopharmaceutical industry with sales approaching $80 billion per year, and has brought forth a large number of the most promising new pharmaceuticals.
More recently, advances in genomics, systems biology and regenerative medicine have produced a broad range of new scientific and medical advances. These advances rely upon a deeper understanding and control of biology than the original 1-gene-biopharmaceuticals and are at earlier stages of development, but promise eventually to bring equal benefits to society.
Webinar content is available with the kind permission of the author(s) solely for the purpose of furthering AIChE’s mission to educate, inform and improve the practice of professional chemical engineering. The content reflects the views, opinions, and recommendations of the presenters. AIChE does not warrant or represent, expressly or by implication, the correctness or accuracy of the content of the information presented. All other uses are forbidden without the express consent of the author(s). For permission to re-use, please contact chemepermissions@aiche.org. Attendee contact information, including email addresses, will be shared with AIChE, with the option to unsubscribe from future communications.
Explore More Areas of Advancement
AIChE Practice+ provides learners with opportunities to work on real-world challenges through industry internships and competitions.
With AIChE Career Discovery®, we'll help you to identify aptitudes and skills you’ll need in order to achieve your full potential at various career stages.
AIChE Credential validates your proficiency with potential employers in areas such as process intensification, safety, sustainability and others.